Polymorphisms of inflammatory markers and risk of essential hypertension in Tatars from Russia

References

• WHO. The 10 leading causes of death in the world, 2000 and 2012. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/ [last accessed December 2014]
   Google Scholar
• Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217–23
   PubMed Web of Science ®Google Scholar
• Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ 2013;3:e003423
   PubMed Web of Science ®Google Scholar
• Padmanabhan S, Newton-Cheh C, Dominiczak AF. Genetic basis of blood pressure and hypertension. Trends Genet 2012;28:397–408
   PubMed Web of Science ®Google Scholar
• Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009;78:539–52
   PubMed Web of Science ®Google Scholar
• Hayashi T, Hasegawa K, Ichinohe N. ICAM-1 expression on endothelium and systemic cytokine production in cutaneous neutrophilic leukocytoclastic vasculitis in NZBxNZWF1 mice. Histol Histopathol 2005;20:45–52
   PubMed Web of Science ®Google Scholar
• McHale JF, Harari OA, Marshall D, Haskard DO. TNF-α and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice. J Immunol 1999;163:3993–4000
   PubMed Web of Science ®Google Scholar
• Kossmann S, Schwenk M, Hausding M, et al. Angiotensin II-induced vascular dysfunction depends on interferon-γ-driven immune cell recruitment and mutual activation of monocytes and NK-cells. Arterioscler Thromb Vasc Biol 2013;33:1313–19
   PubMed Web of Science ®Google Scholar
• Kamba T, Tam BY, Hashizume H, et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 2006;290:H560–76
   PubMed Web of Science ®Google Scholar
• Facemire CS, Nixon AB, Griffiths R, et al. Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression. Hypertension 2009;54:652–8
   PubMed Web of Science ®Google Scholar
• Favorov AV, Andreewski TV, Sudomoina MA, et al. A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases in humans. Genetics 2005;171:2113–21
   PubMed Web of Science ®Google Scholar
• Varughese GI, Patel JV, Tomson J, et al. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial. J Intern Med 2007;261:384–91
   PubMed Web of Science ®Google Scholar
• Nadar SK, Blann AD, Kamath S, et al. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 2004;44:415–22
   PubMed Web of Science ®Google Scholar
• Lee DS, Larson MG, Lunetta KL, et al. Clinical and genetic correlates of soluble P-selectin in the community. J Thromb Haemost 2008;6:20–31
   PubMed Web of Science ®Google Scholar
• Volcik KA, Ballantyne CM, Coresh J, et al. Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2007;195:e76–82
   PubMedGoogle Scholar
• Tregouet DA, Barbaux S, Escolano S, et al. Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum Mol Genet 2002;11:2015–23
   PubMed Web of Science ®Google Scholar
• Marteau JB, Lambert D, Herbeth B, et al. P-selectin polymorphisms’ influences on P-selectin serum concentrations and on their familial correlation: the STANISLAS family study. J Thromb Haemost 2008;6:920–7
   PubMed Web of Science ®Google Scholar
• Patel KD, Nollert MU, McEver RP. P-selectin must extend a sufficient length from the plasma membrane to mediate rolling of neutrophils. J Cell Biol 1995;131:1893–902
   PubMed Web of Science ®Google Scholar
• Mathew JP, Podgoreanu MV, Grocott HP, et al. Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery. J Am Coll Cardiol 2007;49:1934–42
   PubMed Web of Science ®Google Scholar
• Piqueras L, Kubes P, Alvarez A, et al. Angiotensin II Induces leukocyte–endothelial cell interactions in vivo via AT1 and AT2 receptor-mediated P-selectin upregulation. Circulation 2000;102:2118–23
   PubMed Web of Science ®Google Scholar
• Spertini O, Cordey AS, Monai N, et al. P-selectin glycoprotein ligand 1 is a ligand for L-selectin on neutrophils, monocytes, and CD34+ hematopoietic progenitor cells. J Cell Biol 1996;135:523–31
   PubMed Web of Science ®Google Scholar
• Russell AI, Cunninghame Graham DS, Chadha S, et al. No association between E- and L-selectin genes and SLE: soluble L-selectin levels do correlate with genotype and a subset in SLE. Genes and Immun 2005;6:422–9
   PubMed Web of Science ®Google Scholar
• Vannini N, Pfeffer U, Lorusso G, et al. Endothelial cell aging and apoptosis in prevention and disease: E-selectin expression and modulation as a model. Curr Pharm Des 2008;14:221–5
   PubMed Web of Science ®Google Scholar
• Nadar S, Blann AD, Lip GY. Endothelial dysfunction: methods of assessment and application to hypertension. Curr Pharm Des 2004;10:3591–605
   PubMed Web of Science ®Google Scholar
• Malik I, Danesh J, Whincup P, et al. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 2001;358:971–6
   PubMed Web of Science ®Google Scholar
• Stranges S, Rafalson LB, Dmochowski J, et al. Additional contribution of emerging risk factors to the prediction of the risk of type 2 diabetes: evidence from the Western New York Study. Obesity 2008;16:1370–6
   PubMed Web of Science ®Google Scholar
• Hjelstuen A, Anderssen SA, Holme I, et al. Effect of lifestyle and/or statin treatment on soluble markers of atherosclerosis in hypertensives. Scand Cardiovasc J 2007;41:313–20
   PubMed Web of Science ®Google Scholar
• Chang YP, Liu X, Kim JD, et al. Multiple genes for essential-hypertension susceptibility on chromosome 1q. Am J Hum Gen 2007;80:253–64
   PubMed Web of Science ®Google Scholar
• Bielinski SJ, Pankow JS, Li N, et al. ICAM1 and VCAM1 polymorphisms, coronary artery calcium, and circulating levels of soluble ICAM-1: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 2008;201:339–44
   PubMed Web of Science ®Google Scholar
• Bielinski SJ, Reiner AP, Nickerson D, et al. Polymorphisms in the ICAM1 gene predict circulating soluble intercellular adhesion molecule-1 (sICAM-1). Atherosclerosis 2011;216:390–4
   PubMed Web of Science ®Google Scholar
• Puthothu B, Krueger M, Bernhardt M, Heinzmann A. ICAM1 amino-acid variant K469E is associated with paediatric bronchial asthma and elevated sICAM1 levels. Genes Immun 2006;7:322–6
   PubMed Web of Science ®Google Scholar
• Paré G, Chasman DI, Kellogg M, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet 2008;4:e1000118
   PubMed Web of Science ®Google Scholar
• Barbalic M, Dupuis J, Dehghan A, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 2010;19:1863–72
   PubMed Web of Science ®Google Scholar
• Henry TD, Annex BH, McKendall GR, et al. The VIVA trial: vascular endothelial growth factor in ishemia for vascular angiogenesis. Circulation 2003;107:1359–65
   PubMed Web of Science ®Google Scholar
• Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I, Jozwiak L. Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol Dial Transplant 2007;22:827–32
   PubMed Web of Science ®Google Scholar
• Bruyère F, Hovens CM, Marson MN, et al. VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinoma. J Urol 2010;184:1273–8
   PubMed Web of Science ®Google Scholar
• Ungerbäck J, Elander N, Dimberg J, et al. Analysis of VEGF polymorphisms, tumor expression of VEGF mRNA and colorectal cancer susceptibility in a Swedish population. Mol Med Report 2009;2:435–9
   Web of Science ®Google Scholar